Page last updated: 2024-09-04

ezetimibe and Diabetic Neuropathies

ezetimibe has been researched along with Diabetic Neuropathies in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choby, B1
Cabrera Mateos, JL; García Díaz, E; Morera Porras, ÓM; Ramírez Medina, D1
Arias-Carvajal, O; Cardona-Muñoz, EG; Miranda-Díaz, AG; Moreno-Ulloa, A; Pacheco-Moisés, FP; Rodríguez-Carrizalez, AD; Román-Pintos, LM; Troyo-Sanromán, R; Villegas-Rivera, G1

Reviews

1 review(s) available for ezetimibe and Diabetic Neuropathies

ArticleYear
Diabetes Update: Prevention and Management of Diabetes Complications.
    FP essentials, 2017, Volume: 456

    Topics: Anticholesteremic Agents; Antihypertensive Agents; Cardiovascular Diseases; Depression; Diabetes Complications; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Dyslipidemias; Ezetimibe; Gastroparesis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension

2017

Trials

1 trial(s) available for ezetimibe and Diabetic Neuropathies

ArticleYear
Effects of Ezetimibe/Simvastatin and Rosuvastatin on Oxidative Stress in Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Oxidative medicine and cellular longevity, 2015, Volume: 2015

    Topics: Diabetic Neuropathies; Double-Blind Method; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Rosuvastatin Calcium; Simvastatin

2015

Other Studies

1 other study(ies) available for ezetimibe and Diabetic Neuropathies

ArticleYear
Determinants of inertia with lipid-lowering treatment in patients with type 2 diabetes mellitus.
    Endocrinologia, diabetes y nutricion, 2019, Volume: 66, Issue:4

    Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Antihypertensive Agents; Cholesterol, LDL; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Drug Tolerance; Dyslipidemias; Ezetimibe; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypolipidemic Agents; Lipids; Male; Middle Aged; Retrospective Studies; Smoking; Young Adult

2019